| Literature DB >> 25464981 |
Tetsuya Yumoto1, Shingo Ichiba, Nao Umei, Sunao Morisada, Kohei Tsukahara, Keiji Sato, Toyomu Ugawa, Yoshihito Ujike.
Abstract
INTRODUCTION: Aeromonas hydrophila sometimes causes bacteremia, which can be fatal in compromised patients, such as those with liver cirrhosis. We present a case of septic shock due to Aeromonas hydrophila bacteremia in a patient with liver cirrhosis, which was successfully treated with rapid resuscitation and critical care. CASEEntities:
Mesh:
Year: 2014 PMID: 25464981 PMCID: PMC4289225 DOI: 10.1186/1752-1947-8-402
Source DB: PubMed Journal: J Med Case Rep ISSN: 1752-1947
The patient’s arterial blood gas analysis and data findings on admission
| Arterial blood gas analysis (room air) | Complete blood cell count | Biochemistry | |||
|---|---|---|---|---|---|
| pH | 7.196 | WBC | 2150/μL | TP | 5.2g/dL |
| PaCO2 | 21.9mmHg | Hgb | 6.8g/dL | Albumin | 2.5g/dL |
| PaO2 | 91.2mmHg | Hct | 21.5% | AST | 180U/L |
| HCO3 | 8.2mmol/L | PLT | 2.7×104/μL | ALT | 70U/L |
| Base excess | –18.5mmol/L | T-Bil | 1.60mg/dL | ||
| Lactate | 18mmol/L | D-Bil | 0.98mg/dL | ||
| Glucose | 91mg/dL | BUN | 22.8mg/dL | ||
|
| Creatinine | 1.68mg/dL | |||
| PT | 29% | Na | 142mmol/L | ||
| INR | 1.84 | K | 3.6mmol/L | ||
| APTT | 89.9 seconds | Cl | 106mmol/L | ||
| Fibrinogen | <50mg/dL | CRP | 0.37mg/dL | ||
| D-dimer | 6.6μg/mL | Procalcitonin | 3.290ng/mL | ||
| AT3 | 20% | Endotoxin | 14.2pg/mL | ||
ALT, alanine transaminase; APTT, activated partial thromboplastin time; AST, aspartate transaminase; AT3, antithrombin 3; BUN, blood urea nitrogen; Cl, chlorine; CRP, C-reactive protein; D-Bil, direct bilirubin; HCO3, bicarbonate; Hct, hematocrit; Hgb, hemoglobin; INR, international normalized ratio; K, potassium; Na, sodium; PaCO2, carbon dioxide partial pressure arterial; PaO2, oxygen partial pressure arterial; PLT, platelet count; PT, prothrombin time; T-Bil, total bilirubin; TP, total protein; WBC, white blood cell count.
Figure 1Patient’s clinical course during the first 12 hours after his arrival. DBP, diastolic blood pressure; MEPM, meropenem; PMMA, polymethylmethacrylate; PMX, polymyxin B hemoperfusion; SBP, systolic blood pressure; TEIC, teicoplanin.
Figure 2The patient’s clinical course over the first 7 days after his admission. CAZ, ceftazidime; CRP, C-reactive protein; MEPM, meropenem; mPSL, methylprednisolone; PCT, procalcitonin; PMMA, polymethylmethacrylate; PMX, polymyxin B hemoperfusion; SOFA, Sequential Organ Failure Assessment; TEIC, teicoplanin; WBC, white blood cell count.